gastrointestinal endoscopy andObstructive jaundice
Conditions
Interventions
Queue I:None
Queue II:None
Jaundice group:Using Dixon and Massey sequential distribution test formula to calculate the dosage of rimazole
Sponsors
Tianjin Nankai hospital
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1. Patients who used rimazole for painless gastroscopy sedation and painless colonoscopy sedation; 2. Patients with obstructive jaundice (serum tbl>17.1 µ mol/L) treated with rimazole for painless endoscopic sedation.
Exclusion criteria
Exclusion criteria: 1. Patients who are participating or planning to participate in any intervention clinical trial; 2. The investigator believes that there are any other reasons that make the patient unsuitable to participate in this study; 3. Patients using other analgesic or neuroleptic drugs; 4. Patients who suffered from heart, lung, kidney or metabolic diseases; 5. The data of patients who have not signed the informed consent form will not be included and will be removed from the database.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Safety and success rate of remidazolam in sedation by gastroscopy and colonoscopy;Incidence of hypotension and respiratory depression;Sensitivity of remazolam in patients with obstructive jaundice, ED50 and ED95; | — |
Countries
China
Contacts
Public ContactMu Rui
Tianjin Nankai hospital
Outcome results
None listed